Prevalence of HBV, HCV and HIV in Inpatients of a Mental
Health In the only five patients (0.1%) were detected that HBsAg and anti-HCV were concurrently positive. Additionally, 17 patients who anti-HCV was positive had positive anti-HBs. The frequency of HBsAg among genders was significantly higher in the males (4.54%; P: 0.001). There was no significant difference in the prevalence of HBsAg among years. The seroprevalence rate of anti-HBs among genders was no significant difference. The seroprevalence rates of anti-HBs showed an increasing trend between 2011 and 2013 (P <0.001). All of the anti-HCV positive patients were male. There was no significant difference in the prevalence of anti-HCV over the period of three years. Psychiatric patients have less awareness about transmission of infectious diseases and protective measures. In addition, risky sexual behaviors, low quality of life, hospitalization conditions or duration can contribute to an increase in rates of infections. The seropositivity rate of HBsAg among psychiatric patients varies widely by geographical region in the world. While psychiatric patients in some countries such as the United States (23.4%) and Spain (8.8%) have high seropositivity rates of HBsAg; in the countries such as Greece (2%) and Iran (1.2%) have low seropositivity rates (7-10). The observed seroprevalence rate in our study population (4.08%) was less than that of the general Turkish population. In our hospital, the continuous surveillance is been performed, education of the psychiatric patients regarding transmission of blood-borne infections, improving of hospital conditions for patients, which could be a plausible explanation for the low seroprevalence rate of HBsAg in our study population. Immunization, continuous surveillance, education of the psychiatric patients and decrease the duration of hospitalization may be potentially beneficial in decreasing the rate of infections. Reported data on the prevalence of HCV infection in the psychiatric population are highly variable in diverse geographical regions worldwide. The rates of HCV among these patients have been reported as 9% in Greece, 1.8% in Iran and 19.6% in the United States (7, 8, 10) . Elevated infection rates in the psychiatric population may be due to the poverty, risky environments, risky behaviors, overall poor health and medical care in these individuals (7, 8) . Our rates were lower than those found among psychiatric patients in other countries. Low anti-HCV rate in this study may be explained with the surveillance of the patients with risky behaviors, education of the psychiatric patients and improving hospital conditions for patients in our hospital. Additionally, HCV prevalence in the general population in Turkey is already low. This study showed that the prevalence of HBV, HCV and HIV among psychiatric patients were no higher than those in the general population.
